Opendata, web and dolomites

DeltaScan SIGNED

Public private partnership to revolutionize delirium care in hospitals

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 DeltaScan project word cloud

Explore the words cloud of the DeltaScan project. It provides you a very rough idea of what is the project "DeltaScan" about.

benefiting    capturing    eeg    scan    asymp    ready    delirium    equipped    acceptance    patients    time    straight    slower    benefits    billion    acute    monitor    care    majority    medical    financial    gold    least    earlier    hospitals    checks    portable    leaving    size    clinical    deltascan    nurses    society    sme    international    aging    leaders    vital    routine    electroencephalography    citizens    guidelines    nl    launch    standard    market    revolutionizing    173    elderly    fti    blood    wish    benefit    substantially    measuring    detected    subjective    pressure    full    severe    marketplace    soon    absolute    tech    bedside    jobs    prolira    created    dementia    priceless    checklists    million    road    formed    hundreds    organizational    death    detection    opinion    academic    brain    europeans    grow    dying    hospitalized    undetected    sign    recovery    requirement    scale    risk    detect    day    icu    quantify    untreated   

Project "DeltaScan" data sheet

The following table provides information about the project.

Coordinator
PROLIRA BV 

Organization address
address: PADUALAAN 8
city: UTRECHT
postcode: 3584CH
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Project website http://deltascanproject.eu/
 Total cost 4˙484˙637 €
 EC max contribution 2˙994˙425 € (67%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-EIC-FTI-2018-2020
 Funding Scheme IA
 Starting year 2018
 Duration (year-month-day) from 2018-07-01   to  2020-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    PROLIRA BV NL (UTRECHT) coordinator 2˙420˙175.00
2    UNIVERSITAIR MEDISCH CENTRUM UTRECHT NL (UTRECHT) participant 464˙500.00
3    KATHOLIEKE UNIVERSITEIT LEUVEN BE (LEUVEN) participant 72˙500.00
4    CHARITE - UNIVERSITAETSMEDIZIN BERLIN DE (BERLIN) participant 37˙250.00
5    ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM NL (AMSTERDAM) participant 0.00

Map

 Project objective

Prolira, a high-tech SME, has formed a consortium with European academic hospitals (in NL, B, G) and with Key Opinion Leaders who together are revolutionizing delirium care. This is necessary as delirium has severe consequences for patients (death, dementia, slower recovery), hospitals (organizational, time, costs), and society (costs ≈€173 billion). Every year, at least 3 million Europeans are affected by acute brain failure (delirium), especially hospitalized elderly and patients in ICU. And, the size of this problem will grow with our aging society. Delirium is an acute failure of the brain. Each day of delirium increases the risk of dementia or dying. Prolira has created a new vital sign monitor based on portable electroencephalography (EEG) technology: DeltaScan. Nurses can use it during bedside checks to scan brain activity for delirium. This simple step is as important as measuring blood pressure. Currently, nurses are only equipped with subjective checklists to detect delirium, leaving the majority of cases undetected, and untreated. With DeltaScan, delirium is detected more often and earlier, benefiting patients, hospitals, and society. Our medical consortium partners wish to implement DeltaScan into routine care, evaluating the effects and capturing the benefits. It is priceless to get financial support for this clinical testing, which is an absolute requirement for market acceptance. It is a straight road to becoming the Gold Standard in delirium detection and being included in clinical guidelines. EU H2020 FTI funding will allow us to quantify the concrete benefits of improved delirium care, allowing us access to the marketplace and allowing us to benefit society as soon as possible. As well, this funding will allow our international consortium to be well organized and ready for full-scale scale market launch. Prolira will grow substantially in the years directly after the project, creating meaningful jobs for hundreds of EU citizens.

 Deliverables

List of deliverables.
Project website online. The project website contains public information regarding the project, findings, blogs, and publications Demonstrators, pilots, prototypes 2020-04-16 11:23:35

Take a look to the deliverables list in detail:  detailed list of DeltaScan deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "DELTASCAN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "DELTASCAN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.1.)

HYDRACTFLEX (2019)

Full-scale demonstration of a flexible inline production concept for breweries, drawing on water hydraulics

Read More  

Bio-LP-1 (2020)

A novel rapid environmental test for the human pathogen Legionella

Read More  

PAV-DT (2019)

A disruptive technology that enables low cost real-time monitoring of road pavement condition by any ordinary vehicle circulating on the road, and automatically designs plans for predictive maintenance.

Read More